- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04615390
Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation
January 11, 2023 updated by: Sofia Straudi, University Hospital of Ferrara
Recovery Profiles in Patients With COVID-19 Outcomes Undergoing Rehabilitation
COVID19 patients survivors, after discharge from hospital show reduced lung function and reduced ability to exercise.
Furthermore, mental health problems including stress, anxiety and depression and a low quality of life were observed.
The prospective observational study involves COVID19 patients who have needed rehabilitation at the University Hospital of Ferrara.
Patients receive comprehensive rehabilitation based on their specific needs in both acute and subacute rehabilitation.
At the end of hospital rehabilitation, patients are offered a program to be carried out at home for both physical and psychological problems.
A range of demographic and clinical data will be collected.
Patients will also undergo a battery of functional, cognitive and psychological tests at 12, 26 and 52 weeks from the infection onset.
Moreover, a specific assessement (both clinical and instrumental) on the pain symptom experienced, where present, will be done.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sofia Straudi, MD, PhD
- Phone Number: 0532238720
- Email: s.straudi@ospfe.it
Study Locations
-
-
Emilia Romagna
-
Ferrara, Emilia Romagna, Italy, 44124
- Recruiting
- Department of Neuroscience and Rehabilitation, University Hospital of Ferrara
-
Contact:
- Sofia Straudi, MD, PhD
- Phone Number: 0532236185
- Email: s.straudi@ospfe.it
-
Principal Investigator:
- Sofia Straudi, MD, PhD
-
Sub-Investigator:
- Anna Scotti, MD
-
Sub-Investigator:
- Nicola Lamberti, PhD
-
Sub-Investigator:
- Francesco Baldasso, MD
-
Sub-Investigator:
- Antonella Occhi, PT
-
Sub-Investigator:
- Silvia Mottaran, PT
-
Sub-Investigator:
- Ilaria Ferioli, PT
-
Sub-Investigator:
- Fabio Manfredini, MD, PhD
-
Sub-Investigator:
- Giada Milani, PsyD, PhD student
-
Sub-Investigator:
- Giulia Dallagà, PsyD
-
Sub-Investigator:
- Susanna Lavezzi, MD
-
Sub-Investigator:
- Francesca Filippini, PT
-
Sub-Investigator:
- Giulia Bellon, MD
-
Sub-Investigator:
- Alessandra Botti, MD
-
Sub-Investigator:
- Elisabetta Antiga, MD
-
Sub-Investigator:
- Dino De Filippo, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
People infected with COVID-19 and healthy subjects matched for age and sex (pain assessment).
Description
Inclusion Criteria:
- diagnosis of covid19 (WHO criteria);
- indication for respiratory and / or neuromotor rehabilitation treatment
Exclusion Criteria:
- cognitive or communication impairment precluding informed consent
- severe medical conditions
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Borg scale
Time Frame: At the beginning of early rehabilitation
|
Rating perceived exertion on a 10-points scale in which higher values correspond to havier symptomps.
|
At the beginning of early rehabilitation
|
Heart rate
Time Frame: At the beginning of early rehabilitation
|
Heart rate in sitting and standing positions.
|
At the beginning of early rehabilitation
|
Oxygen saturation
Time Frame: At the beginning of early rehabilitation
|
Oxygen saturation in sitting and standing positions.
|
At the beginning of early rehabilitation
|
30 seconds sit-to-stand test
Time Frame: At the beginning of early rehabilitation
|
To measure the strength of the lower limbs.
|
At the beginning of early rehabilitation
|
Change in 1 minute sit-to-stand test between two time points
Time Frame: Month 3, Month 6
|
To measure the strength of the lower limbs.
|
Month 3, Month 6
|
Change in Short form health survey between three time points
Time Frame: At the beginning of early rehabilitation, Month 3, Month 6
|
Is a general health questionnaire for the assessment of the patient's quality of life.
Two summary scores are reported: a mental component score and a physical component score.
The scores may be reported as Z-scores.
|
At the beginning of early rehabilitation, Month 3, Month 6
|
2-minute walking test
Time Frame: At the beginning of early rehabilitation
|
For mobility assessment
|
At the beginning of early rehabilitation
|
Change in 6-minute walking test between two time points
Time Frame: Month 3, Month 6
|
For mobility assessment
|
Month 3, Month 6
|
Change in Functional Independence Measure Scale between two time points
Time Frame: At the beginning of early rehabilitation, Month 3
|
Evaluate the functional autonomy of the patient both on the motor and cognitive side (minumum score:18 maximum score:126 ).
At 3 months the "FIM efficiency" is evaluated as a measure of the efficiency of the rehabilitation intervention.
|
At the beginning of early rehabilitation, Month 3
|
Change in Montreal Cognitive Assessment (MoCA) between two time points
Time Frame: Month 3, Month 6
|
Cognitive screening test.
Higher scores (0-30) are related to a better performance.
|
Month 3, Month 6
|
Cognitive Reserve Index questionnaire
Time Frame: Month 3
|
For measuring cognitive reserve.
It comprehends a overall evaluation of the subject's cognitive status based on social and personal data.
Higher scores underline major cognitive reserves.
|
Month 3
|
Change in Patient Health Questionnaire-9 (PHQ-9) between two time points
Time Frame: Month 3, Month 6
|
To identify the presence of depression and measure its severity.
Score goes from 0 to 27 in which higer numbers represent worse clinical outcomes.
|
Month 3, Month 6
|
Change in Beck Anxiety Inventory (BAI) between two time points
Time Frame: Month 3, Month 6
|
To measure the severity of anxiety.
Higher scores (0-63) indicates more severe anxiety symptoms
|
Month 3, Month 6
|
Change in Connor-Davidson Resilience Scale between two time points
Time Frame: Month 3, Month 6
|
To measure the resilience.
Total score goes from 0 to 40, higher points mean greater resilience.
|
Month 3, Month 6
|
Change in Impact of Event Scale - Revised between two time points
Time Frame: Month 3, Month 6
|
To measure the amount of distress that associate with a specific event.
Total score varies from 0 to 88, higher scores indicate greater post-event distress.
|
Month 3, Month 6
|
Change in General Self Efficacy Scale between two time points
Time Frame: Month 3, Month 6
|
To assess how much people believe they can achieve their goals, despite difficulties.
Total score could be from 4 to 40, higher results show larger self efficacy perception.
|
Month 3, Month 6
|
Change in Pittsburgh Sleep Quality Index (PSQI) between two time points
Time Frame: Month 3, Month 6
|
To assess sleep quality.
Higher scores are related to a worse sleep quality.
|
Month 3, Month 6
|
Covid19 Yorkshire Rehabilitation Scale (C19-YRS)
Time Frame: Referred changes between 3, 6 and 12 months after the symtomps onset
|
Clinical interview (qualitative evaluation) for investigating perceived outcomes after the acute phase of the pathology.
|
Referred changes between 3, 6 and 12 months after the symtomps onset
|
Changes on pain intensity assessed with a Numeric Rating Scale (NRS) between three time points
Time Frame: Month 3, Month 6, Month 12
|
To estimate the amount of pain perceived through a numerical classification in which higher scores indicate greater pain intensity
|
Month 3, Month 6, Month 12
|
Changes in Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) score between three time points
Time Frame: Month 3, Month 6, Month 12
|
To investigate neuropathic charateristics of pain.
The global score goes from 0 to 24, over 12 points it is palusible the presence of neuropathic mechanism.
|
Month 3, Month 6, Month 12
|
Changes in Central Sensitization Inventory (CSI) score between three time points
Time Frame: Month 3, Month 6, Month 12
|
To detect the presence of central sensitization (score between 0-100 in which higher scores suggest the presence of central sensitization)
|
Month 3, Month 6, Month 12
|
Pressure Pain Threshold (PPT)
Time Frame: Month 3, Month 6, Month 12
|
Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally
|
Month 3, Month 6, Month 12
|
Temporal Summation (TS)
Time Frame: Month 3, Month 6, Month 12
|
Changes assessed with an algometer on upper trapezius and rectus femoris bilaterally
|
Month 3, Month 6, Month 12
|
Changes in Pain Catastrophizing Scale (PCS) score between three time points
Time Frame: Month 3, Month 6, Month 12
|
To examine the pain experience felt
|
Month 3, Month 6, Month 12
|
Changes in Tampa Scale of Kinesiophobia (TSK) score between three time points
Time Frame: Month 3, Month 6, Month 12
|
For detecting the pain consequences on movement and related beliefs
|
Month 3, Month 6, Month 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2020
Primary Completion (Anticipated)
June 30, 2023
Study Completion (Anticipated)
November 30, 2023
Study Registration Dates
First Submitted
October 29, 2020
First Submitted That Met QC Criteria
November 2, 2020
First Posted (Actual)
November 4, 2020
Study Record Updates
Last Update Posted (Estimate)
January 13, 2023
Last Update Submitted That Met QC Criteria
January 11, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Covid-19_rehabilitation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early rehabilitation
-
Ospedale Generale Di Zona Moriggia-PelasciniUnknownBrain Injury | Tracheostomy | Neurological RehabilitationItaly
-
Parc de Salut MarAsociación Española contra el CáncerCompletedCancer of Head and NeckSpain
-
Fraser Orthopaedic Research SocietyCompleted
-
China Stroke Databank CenterThe First Affiliated Hospital with Nanjing Medical University; Wuhan University and other collaboratorsRecruitingBrain Ischemia | Stroke RehabilitationChina
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedCOVID-19 Acute Respiratory Distress SyndromeItaly
-
Riphah International UniversityCompletedPost-Op ComplicationPakistan
-
Australian and New Zealand Intensive Care Research...National Health and Medical Research Council, Australia; Monash UniversityRecruitingExtracorporeal Membrane Oxygenation ComplicationAustralia
-
Australian and New Zealand Intensive Care Research...Australian and New Zealand Intensive Care Society Clinical Trials GroupCompletedCritically IllAustralia, New Zealand
-
Asan Medical CenterCompleted
-
Haukeland University HospitalUniversity of Bergen; Municipality of Bergen, Norway; Kavli Research Centre for...Completed